Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis.

Methia N, Louache F, Vainchenker W, Wendling F.

Blood. 1993 Sep 1;82(5):1395-401.

2.

c-mpl, the thrombopoietin receptor.

Vainchenker W, Methia N, Debili N, Titeux M, Wendling F.

Thromb Haemost. 1995 Jul;74(1):526-8. Review.

PMID:
8578519
3.

Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.

Drexler HG, Quentmeier H.

Leukemia. 1996 Sep;10(9):1405-21. Review.

PMID:
8751457
4.

Thrombopoietin and the humoral regulation of thrombocytopoiesis.

Eaton DL, de Sauvage FJ.

Curr Opin Hematol. 1995 May;2(3):167-71. Review.

PMID:
9371990
5.

Clonality assays and megakaryocyte culture techniques in essential thrombocythemia.

Yan L, Elkassar N, Gardin C, Briere J.

Leuk Lymphoma. 1996 Sep;22 Suppl 1:31-40. Review.

PMID:
8951770
6.
7.

c-mpl expression in hematologic disorders.

Bouscary D, Prudhomme C, Quesnel B, Melle J, Picard F, Dreyfus F.

Leuk Lymphoma. 1995 Mar;17(1-2):19-26. Review.

PMID:
7773160
8.
9.

Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.

Alexander WS, Roberts AW, Maurer AB, Nicola NA, Dunn AR, Metcalf D.

Stem Cells. 1996;14 Suppl 1:124-32. Review.

10.

Role for C-MPL and its ligand thrombopoietin in early hematopoiesis.

Katayama N, Itoh R, Kato T, Sugawara T, Mahmud N, Ohishi K, Masuya M, Aoki M, Minami N, Miyazaki H, Shiku H.

Leuk Lymphoma. 1997 Dec;28(1-2):51-6. Review.

PMID:
9498703
11.

The structure, biology and potential therapeutic applications of recombinant thrombopoietin.

Lok S, Foster DC.

Stem Cells. 1994 Nov;12(6):586-98. Review.

PMID:
7881359
12.

From the v-mpl oncogene to thrombopoietin.

Methia N, Debili N, Titeux M, Vainchenker W, Wendling F.

C R Acad Sci III. 1995 Apr;318(4):479-82. Review.

PMID:
7648360
13.

Hierarchical structure of human megakaryocyte progenitor cells.

Hoffman R, Murrav LJ, Young JC, Luens KM, Bruno E.

Stem Cells. 1996;14 Suppl 1:75-81. Review.

14.

[Thrombopoietin and megakaryocyte differentiation].

Vainchenker W, Debili N, Norol F, Wendling F.

Schweiz Med Wochenschr. 1998 Oct 17;128(42):1575-81. Review. French.

PMID:
9824885
15.

Role of thrombopoietin in hematopoietic stem cell and progenitor regulation.

Drachman JG.

Curr Opin Hematol. 2000 May;7(3):183-90. Review.

PMID:
10786657
16.

The mpl ligand: molecular and cellular biology of the critical regulator of megakaryocyte development.

Kaushansky K.

Stem Cells. 1994;12 Suppl 1:91-6; discussion 96-7. Review.

PMID:
7696972
17.

Megakaryocyte development and platelet production.

Deutsch VR, Tomer A.

Br J Haematol. 2006 Sep;134(5):453-66. Review.

PMID:
16856888
18.

Antisense inhibition of oncogene expression.

Neckers L, Whitesell L, Rosolen A, Geselowitz DA.

Crit Rev Oncog. 1992;3(1-2):175-231. Review.

PMID:
1312868
19.

Antisense strategies to characterize the role of genes and oncogenes involved in myeloid differentiation.

Ferrari S, Manfredini R, Grande A, Torelli U.

Ann N Y Acad Sci. 1992 Oct 28;660:11-26. Review. No abstract available.

PMID:
1340115
20.

Antisense oligonucleotides.

Calabretta B, Skorski T, Zon G.

Semin Cancer Biol. 1992 Dec;3(6):391-8. Review.

PMID:
1286160

Supplemental Content

Support Center